Skip to main content
. 2024 May 13;11(6):ofae265. doi: 10.1093/ofid/ofae265

Table 1.

Characteristics of Patients at 3 Urban Human Immunodeficiency Virus Clinics Who Were Surveyed on Appeal of Self- or Partner/Friend/Family-Administered Long-acting Injectable Cabotegravir/Rilpivirine, December 2021–May 2022

Characteristic Total Patients
(N = 370)
Site
 San Francisco, California (Ward 86) 143 (38.7)
 Chicago, Illinois (University of Chicago) 107 (28.9)
 Atlanta, Georgia (Grady Ponce de Leon Center) 120 (32.4)
Administered in Spanish 16 (4.3)
Age, y, median (range) 45.5 (19.0–77.0)
Age group, y
 18–29 57 (15.4)
 30–49 158 (42.7)
 ≥50 155 (41.9)
Race/ethnicity
 Non-Latinx Black 220 (59.5)
 Non-Latinx White 61 (16.5)
 Latinx 47 (12.7)
 Non-Latinx Other 42 (11.4)
Gender
 Cisgender female 97 (26.3)
 Cisgender male 245 (66.4)
 Transgender female 19 (5.2)
 Gender minority (nonbinary, genderqueer) 9 (2.4)
Sexual orientation
 Gay 137 (37.3)
 Bisexual 50 (13.6)
 Heterosexual 163 (44.4)
 Other 17 (4.6)
Housing
 Stably housed 244 (66.0)
 Unstably housed 114 (30.8)
 Homeless 12 (3.2)
Education
 Bachelor’s degree/Any postgraduate 51 (13.8)
 Some college/associate’s or technical degree 132 (35.7)
 High school/General Education Development 112 (30.3)
 Less than high school 75 (20.2)
Description of financial situation
 Comfortable, can purchase extras 66 (18.1)
 Have the necessities/money to cover needs 125 (34.3)
 Barely paying the bills 82 (22.5)
 Struggling to survive 92 (25.2)
Opiate or stimulant use past 30 d 71 (19.3)
Health literacya
 Extremely low 52 (14.6)
 Moderately low 91 (25.5)
 Adequate 214 (59.9)
Currently on oral antiretroviral therapy 353 (98.3)
Well-engaged in careb 269 (72.7)
Most recent viral load ≥200 copies/mLc 75 (22.0)
Primary care visits in past 12 mo
 <2 visits scheduled 41 (11.1)
 <2 visits scheduled and attended 43 (11.6)
 ≥2 visits attended 286 (77.3)

Data are presented as No. (%) unless otherwise indicated.

aBased on the 4-item Brief Health Literacy Screening Tool.

bDefined as virally suppressed (HIV-1 RNA <200 copies/mL) or ≥2 primary care visits attended in prior 12 months.

cTwenty-nine (7.8%) did not have a viral load result in their medical record in the past 12 months.